CAPO News

Dear colleagues,

As the Guest Editors of the Special Issue in Current Oncology described below, we encourage you to consider contributing a paper.

Special Issue Title: Supportive Care Needs of Cancer Patients and Caregivers

Website: https://lnkd.in/gdncaCj

Deadline for manuscript submissions: July 31, 2021

Papers will be published on an ongoing basis, immediately upon acceptance after peer review (generally within one week). A publication fee of 1200 CHF will be applied for each accepted paper submitted in 2021 (papers submitted after 30 June 2021 the APC will be 1600 CHF). No extra fees will be applied for color figures.

As an incentive, we have two free publications to offer. To apply to have your paper published free of charge, please send us an abstract and tentative title by May 31, 2021. Submitted abstracts will be evaluated based on innovation, scientific merit, need and whether they have an alternative source of funding.

Sincerely,

Dr. Jackie Bender and Dr. Sylvie Lambert

CAPO members can access the discount code and more information by going to Member Resources.

Current Oncology (ISSN 1718-7729) is an international, peer-reviewed, open access journal published online by MDPI (from Volume 28 Issue 1-2021). Established in 1994, the journal represents a multidisciplinary medium for clinical oncologists to report and review progress in the management of this disease. Dr. Shahid Ahmed from the University of Saskatchewan has served as Editor-in-Chief of Current Oncology since June 2023. The journal is supported by an international editorial board consisting of a distinguished team of cancer researchers from major institutes from Canada and around the world (http://www.mdpi.com/journal/curroncol/editors). Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine. Current Oncology is indexed by important databases, including SCIE, PubMed, MEDLINE, and Scopus. Current Oncology received an increased Impact Factor for 2023 of 2.8, following an increased CiteScore of 3.3. Current Oncology now ranks in Q2 in the “Oncology” category (157/322) which represents our ranking relative to other journals in the same field. More information about the journal can be accessed at: http://www.mdpi.com/journal/curroncol.

CAPO members enjoy author fee discounts with Current Oncology.  Email Karen for more info at karen.irwin@mdpi.com.

NOTE:  When you apply for research funding, please inquire whether your granting agency allows the costs of open access publishing, such as Article Processing Charges, to be included in the grant budget.  More and more, granting agencies are encouraging or even requiring that all papers resulting from funded research must be published in Open Access journals.

CAPO Statement on COVID19

Dear Members of the CAPO Community,

These are incredibly difficult times full of uncertainty and fear. For our patients, colleagues and loved ones living with cancer, things are especially challenging.

As always, the psychosocial well-being of our patients, colleagues and family members is our utmost priority. 

We also understand that there is an overwhelming amount of information circulating regarding COVID-19.

We have gathered the following resources to help you navigate this unprecedented time.

• Cancer and COVID-19  
• Mental Health and Coping During COVID-19
• Managing Fears and Anxiety around the Coronavirus (COVID-19)
• Public Health Agency of Canada

As of right now, CAPO's 35th Annual Conference scheduled for July 15 to 17 in St. John’s, Newfoundland, is planned to proceed as scheduled. We are however monitoring the situation very closely and will advise if this changes. 

WEBINAR – MARCH 20, 2020. Dr. Doris Howell: Proactive remote monitoring and real-time symptom management using mobile technology: a feasibility study. Please join us.

As a community – we are here for you.

March 6 is World Lymphedema Day! Lymphedema is chronic inflammatory condition that can develop after cancer treatment. Download the poster

For the first time ever, the Congress will be "Patients Included". We are pleased to welcome the following advocates:

• Victoria Forster @vickyyyf, @cancersurvSM

• Margaret Ng: Over 10 years experience working in workplace wellness and health promotion my mission is to support health, healing, and well-being so others can thrive in life.

• Karen Ladner Haas @caringcancermom

• Lorna Larsen @TeamShan: I am honoured to receive a 2019 IPOS/CAPO World Congress of Psycho-Oncology patient and family advocate scholarship. I look forward to participating in the Congress, sharing my daughter Shanna's Story and my efforts to make a positive difference in the adolescent and young adult (AYA) cancer journey. Shanna (Shan) lost her life to breast cancer at the age of twenty-four. As part of my grief process, I have advocated strongly to help improve AYA cancer outcomes across the continuum from awareness to palliative care. All in Shan's memory!

• Jill Hamer-Wilson @JillHW

Innovation Grants/Subventions pour l'innovation:

Innovation Grants support the highest quality creative problem solving in cancer research. The goal of the Innovation program is to support the development and testing of transformative, paradigm-shifting concepts and approaches to address problems in cancer research, enhance our understanding of cancer, and generate novel approaches to confront the challenges we face in defeating cancer.

Budgets awarded may be up to $100,000 per year and a maximum of $200,000 per grant.

It is anticipated that approximately 30 grants will be awarded in this competition.

Please note the following:

• Innovation Grants are offered once per year. The timeline below is anticipated to be consistent going forward.
• This competition consists of a full application only, abstract registration is not required
• There must be no (0%) overlap with any pending or held grant applications (i.e. 100% unique aims are required - conceptual overlap is acceptable but must be described by the applicant)

Special funding calls within the Innovation Grant competition envelope:

• Applications relevant to breast cancer research are encouraged
• Applications relevant to skin cancer are encouraged
• As a result of a generous donation, funding for one application with a focus on early detection, diagnosis, and/or treatment of malignant mixed Müllerian tumours (MMMT) is available
• Additional funds may be available from the Lotte and John Hecht Memorial Foundation to support innovative projects focused on the application of complementary and alternative approaches in cancer treatment and control

Full application deadline: October 15, 2019

Results announcement: April, 2020

Anticipated start date: May 1, 2020

Please review the full Program Description on our website.

Veuillez consulter la description complète du programme sur notre site Web.

Innovation to Impact Grants/Subventions d’une innovation à un impact:

*Note update to eligibility criteria regarding pursuit of ‘logical next steps’ from an Innovation or CBCF grant.

These grants are intended to support the next phase following a productive CCS Innovation Grant or CBCF research grant, with the goal of working towards or achieving a significant impact on cancer.

Applicants are required to articulate significant achievements from the original Innovation/CBCF Grant (i.e., significant new knowledge, publications, intellectual property, technology development, or relevant endpoints) and clearly describe and justify the progression to the new research proposed. In other words, the original grant and the i2I proposal must be linked by their overarching goal or objective. Applicants must also describe the potential for impact of the proposed project on cancer.

Budgets awarded may be up to $150,000 per year for up to 3 years, to a maximum of $450,000 per grant.

It is anticipated that approximately 15 grants will be awarded in this competition.

Please note that only investigators with a funded Innovation or CBCF research grant with a project end date between January 1, 2017 and April 30, 2020 are eligible for this program.

Full application deadline: October 15, 2019

Results announcement: April 2020

Anticipated start date: May 1, 2020

Please review the full Program Description on our website.

Veuillez consulter la description complète du programme sur notre site Web.

Travel Awards/Bourses de déplacement :

These awards are intended to defray the travel costs associated with making a scientific presentation as a first author or presenter at a conference, symposium or other appropriate professional meeting. PhD, MD, or MD/PhD students, and post-doctoral/medical/clinical fellows are eligible to apply.

There are three competitions in 2019. It is anticipated that approximately 10 Travel Awards will be awarded in each competition (approximately 30 awards per year).

Please note the following:

• Applications will only be accepted for conference dates within 6 months following the funding start date.
• Eligible expenses include: 1) Conference registration fees; 2) Accommodations; and 3) Transportation, and will not exceed $2,000.
• Individuals may receive this award only once per stage of training (PhD, MD, Postdoctoral fellow). Unsuccessful applicants may reapply in subsequent competitions.

Full application deadline: September 15, 2019

Results announcement: November, 2019

Funding start date: December 1, 2019

Please visit the Canadian Cancer Society research website for program and application information www.cancer.ca/research.

Les renseignements relatifs au programme et à la demande se trouvent sur le site Web de recherche de la Société canadienne du cancer (SCC), au www.cancer.ca/research.

The shared mission of the Canadian Association of Psychosocial Oncology (CAPO) and the International Psycho-Oncology Society (IPOS) is to foster the science and practice of psychosocial oncology to improve the care for people affected by cancer through partnerships, research, public policy, advocacy and education. Our 2019 World Congress will create an opportunity to bring together an international body of health care professionals. This forum encourages new global partnerships and allows for the dissemination of ground-breaking research to professionals and the general public about psycho-oncology, that is, the psychosocial (psychiatric, psychological, social, behavioural, ethical) and psychobiological aspects of oncology.  Finally, this forum allows us to recognize exceptional contributions from around the world to the field of psycho-oncology through our awards of excellence.

The following financial support is being made available to patient advocates interested in attending the 2019 Congress:

• Five (5) $1,000 CAD travel/accommodation scholarships to be paid directly to recipients at the Congress by cheque accompanied by complimentary congress registration valued at $750 CAD each (does not include the pre-congress workshops or dinner adventure).

In order to qualify, applicants must:

1. Be residing in Canada.
2. Identify themselves as a patient/family advocate (have an active role in communicating their cancer experience).
3. Be active on social media.
4. Complete an online application by July 31, 2019.
5. If selected, must submit a 250 to 500-word summary of key learnings from the congress that will be published on our website https://capo.ca/home-new, and also in the CAPO e-newsletter, CAPO Connection. Submission must be made by December 31, 2019.

Online application review and selection:

1. Applications are accepted online only. Confirmation of submission will NOT be issued. To submit, please go to https://www.surveymonkey.com/r/9MMWLYT.
2. A panel of three current CAPO members (void of any conflict of interest), one in which must be a current CAPO board member, will review applications and select the five recipients.
3. Final decision on the five recipients selected will be issued via email by no later than August 16, 2019.

We are pleased to provide you with early access to the modernized Canadian Strategy for Cancer Control – a 10-year roadmap to improve equity in the cancer system and to deliver world-class cancer care to all Canadians, while focusing on a sustainable healthcare system for the future. This Strategy focuses on driving measurable change on the most pressing challenges for the next decade with five priorities:  Decrease the risk of people getting cancer Diagnose cancer faster, accurately and at an earlier stage  Deliver high-quality care in a sustainable, world-class system Eliminate barriers to people getting the care they need Deliver information and supports for people living with cancer, families and caregivers  First Nations, Inuit, and Métis advisors, communities , governments, and organizations were engaged in all parts of Canada using a parallel process to ensure separate, respectful and Peoples-specific priorities and challenges were understood and reflected in the refreshed Strategy.  In addition to the five priorities above, the Strategy includes three priorities identified by First Nations, Inuit and Métis, each with Peoples-specific actions. You can access the Strategy and other materials using the links below.  Materials  Download the modernized Canadian Strategy for Cancer Control  Download Refreshing the Canadian Strategy for Cancer Control: Patient, Public and Stakeholder Engagement Summary Report   Communications Toolkit We invite you to use this Communications Toolkit to share the messages and images on June 4, 2019 and beyond to help raise awareness of the refreshed Strategy. The toolkit is available in English and French, and includes:  Social media posts Email copy Website content (Summary option and Detailed option) Newsletter content To show your support: Use the Communications Toolkit to spread the message on and after June 4, 2019  Like, comment and share the Partnership’s social media posts across Twitter and Facebook Join the social conversation using hashtag #CDNCancerStrategy in English and#StratégieCASurLeCancer in French. Thank you for your interest in the Canadian Partnership Against Cancer – we appreciate your support.  Cindy Morton  Chief Executive Officer  Canadian Partnership Against Cancer  Nous sommes heureux de vous offrir un accès anticipé à la version modernisée de laStratégie canadienne de lutte contre le cancer – une feuille de route sur 10 ans visant à améliorer l’équité au sein du système de lutte contre le cancer et à offrir des soins de calibre mondial à l’ensemble des Canadiens, tout en se concentrant sur la mise en place d’un système de santé durable pour l’avenir. La Stratégie vise à favoriser des changements mesurables pour les défis les plus urgents au cours des dix prochaines années, avec cinq priorités :  Réduire le risque de cancer dans la population Diagnostiquer le cancer plus rapidement, avec exactitude et à un stade plus précoce Offrir des soins de grande qualité dans le cadre d’un système durable et de calibre mondial  Éliminer les obstacles qui empêchent les gens d’obtenir les soins dont ils ont besoin  Offrir de l’information et du soutien aux personnes atteintes de cancer, aux familles et aux aidants Des conseillers, des communautés, des gouvernements et des organisations des Premières Nations, des Inuits et des Métis ont été mobilisés partout au Canada dans le cadre d’un processus parallèle pour faire en sorte que soient compris et intégrés dans la Stratégie actualisée les priorités et les défis propres aux peuples autochtones, de manière respectueuse et distincte.  En plus des cinq priorités ci-dessus, la Stratégie comprend trois priorités déterminées par les Premières Nations, les Inuits et les Métis, et chacune d’entre elles s’accompagne de mesures propres aux peuples autochtones. Documents   Téléchargez la version modernisée de la Stratégie canadienne de lutte contre le cancer Téléchargez la publication intitulée Actualisation de la Stratégie canadienne de lutte contre le cancer : rapport sommaire sur la mobilisation des patients, du public et des intervenants Trousse d’outils pour les communications Nous vous invitons à utiliser cette Trousse d’outils pour les communications afin de partager les messages et les images qu’elle contient à partir du 4 juin 2019 pour aider à faire connaître la Stratégie actualisée. La trousse d’outils existe en français et en anglais, et comprend ce qui suit :  Publications pour les médias sociaux Contenu pour les courriels Contenu pour les sites Web (option courte et option détaillée) Contenu pour les infolettres Pour montrer votre soutien : Utilisez la Trousse d’outils pour les communications afin de diffuser le message dès le 4 juin 2019.  Aimez les publications du Partenariat sur les médias sociaux, laissez-y des commentaires ou partagez-les sur Twitter et Facebook. Joignez-vous à la conversation sur les médias sociaux au moyen du mot-dièse#StratégieCASurLeCancer en français et #CDNCancerStrategy en anglais. Merci de votre intérêt envers le Partenariat canadien contre le cancer – nous apprécions votre soutien.   Cindy Morton  Présidente-directrice générale  Partenariat canadien contre le cancer

The Canadian Association of Psychosocial Oncology (CAPO) and the International Psycho-Oncology Society (IPOS) are pleased to receive the support of Bell Let’s Talk for this year’s 21^st annual World Congress of Psycho-Oncology. The Congress will take place this year in Banff, Alberta from September 23-26. The theme for the Congress is A Global Call for Action: Implementing Psychosocial Oncology Research for Optimal Cancer Care.

As Visionary Sponsor, Bell Let’s Talk is supporting more than 800 international health care leaders, scientists and researchers from over 60 countries who will be gathering to share and learn how to help cancer patients and their families cope with the devastating emotional and mental health impact of the disease.

“We are very excited to have Bell Let’s Talk join us this year in support of our World Congress,” said Dr. Fiona Schulte, President and Co-Chair of the IPOS World Congress and President, Canadian Association of Psychosocial Oncology (CAPO). “The impact of their support will resound globally with the community of leading oncologists who will be engaging with patients, care-givers and family members through their cancer journeys.”

Cancer is the second leading cause of death internationally. In 2018 alone, there were more than 18 million new cases, with just over a 50 per cent survival rate. Cancer impacts everyone – from patients, to friends, to loved ones.

The World Congress will bring together an international community of health care leaders, scientists and researchers who will take their knowledge back to improve patient and family care. This forum encourages new global partnerships and allows for the dissemination of ground-breaking research to professionals and the general public about psycho-oncology that will transform the cancer experience and improve the quality of life for millions of people globally.

Since 2010, the Bell Let’s Talk mental health initiative has been leading a conversation about the impact of mental illness and the stigma that surrounds it, while also funding programs focused on 4 mental health action pillars: anti-stigma, care and access, new research and workplace leadership. To learn more, please visit Bell.ca/LetsTalk.

For more information on the World Congress, please visit: https://ipos2019.com/

Under the direction of the CAPO Clinical Advisory Committee a working group of CAPO members has developing a position paper on MAID. This position statement is intended to clarify the role of psychosocial oncology services and psychosocial oncology clinicians in responding to patient inquiries about MAID. This paper can be accessed at:

CAPO MAID Position Statement PDF

We thank Drs Doris Howell, Keith Wilson, Madeline Li, Harvey Chochinov, Eric Wasylenko, Jennifer Bell, Jacynthe Rivest and Chad Hammond for their work on this position statement.

A CAPO webinar is being planned on this topic for 12pm EST, November 22, 2017. Details will be circulated at a later date.

CAPO is looking for in-kind support to translate this position statement into French. If members are aware of local resources available for in-kind translation services, please contact capo@funnel.ca